{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:00:04Z","timestamp":1791349204521,"version":"4.3.1"},"reference-count":166,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gonadotropin-releasing hormone (GnRH) is the hypothalamic factor that mediates reproductive competence. Intermittent GnRH secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. LH and FSH then stimulate sex steroid hormone synthesis and gametogenesis in the gonads to ensure reproductive competence. The pituitary requires pulsatile stimulation by GnRH to synthesize and release the gonadotropins LH and FSH. Clinically, native GnRH is used in a pump delivery system to create an episodic delivery pattern to restore hormonal defects in patients with hypogonadotropic hypogonadism. Agonists of GnRH are delivered in a continuous mode to turn off reproductive function by inhibiting gonadotropin production, thus lowering sex steroid production, resulting in medical castration. They have been used in endocrine disorders such as precocious puberty, endometriosis and leiomyomata, but are also studied extensively in hormone-dependent malignancies. The detection of GnRH and its receptor in other tissues, including the breast, ovary, endometrium, placenta and prostate suggested that GnRH agonists and antagonists may also have direct actions at peripheral targets. This paper reviews the current data concerning differential control of GnRH and GnRH receptor expression and signaling in the hypothalamic\u2013pituitary axis and extrapituitary tissues. Using these data as a backdrop, we then review the literature about the action of GnRH in cancer cells, the utility of GnRH analogs in various malignancies and then update the research in novel therapies targeted to the GnRH receptor in cancer cells to promote anti-proliferative effects and control of tumor burden.<\/jats:p>","DOI":"10.1677\/erc.1.00777","type":"journal-article","created":{"date-parts":[[2005,1,21]],"date-time":"2005-01-21T16:19:42Z","timestamp":1106324382000},"page":"725-748","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":139,"title":["Gonadotropin-releasing hormone and its receptor in normal and malignant cells"],"prefix":"10.1530","volume":"11","author":[{"given":"G S","family":"Harrison","sequence":"first","affiliation":[{"name":"1University of Colorado Health Sciences, Department of Medicine, 4200 East Ninth Avenue, Denver, Colorado 80262, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Wierman","sequence":"additional","affiliation":[{"name":"1University of Colorado Health Sciences, Department of Medicine, 4200 East Ninth Avenue, Denver, Colorado 80262, USA"},{"name":"2Veterans Affairs Medical Center, Denver, Colorado 80220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Nett","sequence":"additional","affiliation":[{"name":"3Colorado State University, Department of Physiology, Animal Reproduction and Biotechnology Laboratory, Fort Collins, Colorado 80523, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Glode","sequence":"additional","affiliation":[{"name":"1University of Colorado Health Sciences, Department of Medicine, 4200 East Ninth Avenue, Denver, Colorado 80262, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070905553442500_ABOU-JAWDE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Abou-Jawde\n            R\n          , Choueiri T, Alemany C & Mekhail T 2003 An overview of targeted treatments in cancer. Clinical Therapeutics252121\u20132137.","DOI":"10.1016\/S0149-2918(03)80209-6"},{"key":"2026070905553442500_ALBERTSEN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Albertsen\n            PC\n          , Fryback DG, Storer BE, Kolon TF & Fine J 1995 Long-term survival among men with conservatively treated localized prostate cancer. Journal of the American Medical Association274626\u2013631.","DOI":"10.1001\/jama.1995.03530080042039"},{"key":"2026070905553442500_ALLEN-2002","unstructured":"Allen\n            TM\n          \n          2002 Ligand-targeted therapeutics in anticancer therapy. Nature Reviews of Cancer2750\u2013763."},{"key":"2026070905553442500_ANONYMOUS-1984","unstructured":"Anonymous 1984 Leuprolide versus diethylstilbestrol for metastatic prostate cancer. The Leuprolide Study Group. New England Journal of Medicine3111281\u20131286."},{"key":"2026070905553442500_ANONYMOUS-1996","unstructured":"Anonymous 1996 Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group. Lancet3481189\u20131196."},{"key":"2026070905553442500_ANONYMOUS-2000","unstructured":"Anonymous 2000 Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists\u2019 Collaborative Group. Lancet3551491\u20131498."},{"key":"2026070905553442500_ANONYMOUS-2003","unstructured":"Anonymous 2003 Urologists face major cut in AWP of cancer drugs. Urology Times (1 December)."},{"key":"2026070905553442500_AVILA-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Avila\n            DM\n          , Zoppi S & McPhaul MJ 2001 The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer. Journal of Steroid Biochemistry and Molecular Biology76135\u2013142.","DOI":"10.1016\/S0960-0760(00)00158-8"},{"key":"2026070905553442500_BAHK-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Bahk\n            JY\n          , Hyun JS, Chung SH, Lee H, Kim MO, Lee BH & Choi WS 1995 Stage specific identification of the expression of GnRH mRNA and localization of the GnRH receptor in mature rat and adult human testis. Journal of Urology1541958\u20131961.","DOI":"10.1097\/00005392-199511000-00105"},{"key":"2026070905553442500_BARBIERI-1998","unstructured":"Barbieri\n            RL\n          \n          1998 Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment. Journal of Reproductive Medicine43287\u2013292."},{"key":"2026070905553442500_BAST-ETAL-1996","unstructured":"Bast\n            R\n          , Zalutsky M & Frankel A 1996 Monoclonal serotherapy. In Cancer Medicine, Edn 4 pp 1245\u20131262. Eds J Holland, E Frei, R Bast, D Morton, D Kufe & R Weichselbaum. Baltimore: Williams and Wilkins."},{"key":"2026070905553442500_BEDECARRATS-AND-KAISER-2003","doi-asserted-by":"crossref","unstructured":"Bedecarrats\n            GY\n           & Kaiser UB 2003 Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration. Endocrinology1441802\u20131811.","DOI":"10.1210\/en.2002-221140"},{"key":"2026070905553442500_BEN-YEHUDAH-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ben-Yehudah\n            A\n          , Yarkoni S, Nechushtan A, Belostotsky R & Lorberboum-Galski H 1999 Linker-based GnRH-PE chimeric proteins inhibit cancer growth in nude mice. Medical Oncology1638\u201345.","DOI":"10.1007\/BF02787357"},{"key":"2026070905553442500_BOCCARDO-ETAL-1999","unstructured":"Boccardo\n            F\n          , Blamey R, Klijn JG, Tominaga T, Duchateau L & Sylvester R 1999 LHRH-Agonist (LHRH-A)+tamoxifen (TAM) versus LHRH-A alone in premenopausal women with advanced breast cancer (ABC): results of a meta-analysis of four trials. Proceedings of the American Society of Clinical Oncology18110a (Abstract)."},{"key":"2026070905553442500_BOLLA-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Bolla\n            M\n          , Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T et al.1997 Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New England Journal of Medicine337295\u2013300.","DOI":"10.1056\/NEJM199707313370502"},{"key":"2026070905553442500_BONO-ETAL-2002","unstructured":"Bono\n            AV\n          , Salvadore M & Celato N 2002 Gonadotropin-releasing hormone receptors in prostate tissue. Analytical and Quantitative Cytology and Histology24221\u2013227."},{"key":"2026070905553442500_BORRONI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Borroni\n            R\n          , Di Blasio AM, Gaffuri B, Santorsola R, Busacca M, Vigano P & Vignali M 2000 Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate. Molecular and Cellular Endocrinology15937\u201343.","DOI":"10.1016\/S0303-7207(99)00199-9"},{"key":"2026070905553442500_BOTTE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Botte\n            MC\n          , Chamagne AM, Carre MC, Counis R & Kottler ML 1998 Fetal expression of GnRH and GnRH receptor genes in rat testis and ovary. Journal of Endocrinology159179\u2013189.","DOI":"10.1677\/joe.0.1590179"},{"key":"2026070905553442500_BOTTE-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Botte\n            MC\n          , Lerrant Y, Lozach A, Berault A, Counis R & Kottler ML 1999 LH down-regulates gonadotropin-releasing hormone (GnRH) receptor, but not GnRH, mRNA levels in the rat testis. Journal of Endocrinology162409\u2013415.","DOI":"10.1677\/joe.0.1620409"},{"key":"2026070905553442500_BRINKMANN-AND-PASTAN-1994","doi-asserted-by":"crossref","unstructured":"Brinkmann\n            U\n           & Pastan I 1994 Immunotoxins against cancer. Biochimica et Biophysica Acta119827\u201345.","DOI":"10.1016\/0304-419X(94)90004-3"},{"key":"2026070905553442500_BUZDAR-2004","doi-asserted-by":"crossref","unstructured":"Buzdar\n            AU\n          \n          2004 Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. Clinical Cancer Research10355S\u2013361S.","DOI":"10.1158\/1078-0432.CCR-031203"},{"key":"2026070905553442500_CASTIGLIONE-GERTSCH-ETAL-2003","unstructured":"Castiglione-Gertsch\n            M\n          , O\u2019Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M & Gelber RD 2003 Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. Journal of the National Cancer Institute951833\u20131846."},{"key":"2026070905553442500_CHATZAKI-ETAL-1996","unstructured":"Chatzaki\n            E\n          , Bax CM, Eidne KA, Anderson L, Grudzinskas JG & Gallagher CJ 1996 The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Research562059\u20132065."},{"key":"2026070905553442500_CHEN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Chen\n            A\n          , Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y & Levite M 2002 The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nature Medicine81421\u20131426.","DOI":"10.1038\/nm1202-801"},{"key":"2026070905553442500_CHENG-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Cheng\n            CK\n          , Yeung CM, Chow BK & Leung PC 2002 Characterization of a new upstream GnRH receptor promoter in human ovarian granulosa-luteal cells. Molecular Endocrinology161552\u20131564.","DOI":"10.1210\/mend.16.7.0869"},{"key":"2026070905553442500_CHODAK-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Chodak\n            GW\n          , Vogelzang NJ, Caplan RJ, Soloway M & Smith JA 1991 Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. Journal of the American Medical Association265618\u2013621.","DOI":"10.1001\/jama.1991.03460050072023"},{"key":"2026070905553442500_CHON-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Chon\n            JK\n          , Jacobs SC & Naslund MJ 2000 The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer. Journal of Urology164735\u2013737.","DOI":"10.1097\/00005392-200009010-00027"},{"key":"2026070905553442500_CHOU-ETAL-2003A","doi-asserted-by":"crossref","unstructured":"Chou\n            CS\n          , MacCalman CD & Leung PC 2003a Differential effects of gonadotropin-releasing hormone I and II on the urokinase-type plasminogen activator\/plasminogen activator inhibitor system in human decidual stromal cells in vitro.Journal of Clinical Endocrinology and Metabolism883806\u20133815.","DOI":"10.1210\/jc.2002-021955"},{"key":"2026070905553442500_CHOU-ETAL-2003B","doi-asserted-by":"crossref","unstructured":"Chou\n            CS\n          , Tai CJ, MacCalman CD & Leung PC 2003b Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual stromal cells in vitro.Journal of Clinical Endocrinology and Metabolism88680\u2013688.","DOI":"10.1210\/jc.2002-021277"},{"key":"2026070905553442500_CHOU-ETAL-2003C","doi-asserted-by":"crossref","unstructured":"Chou\n            CS\n          , Zhu H, MacCalman CD & Leung PC 2003c Regulatory effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinases-1 in primary cultures of human extravillous cytotrophoblasts. Journal of Clinical Endocrinology and Metabolism884781\u20134790.","DOI":"10.1210\/jc.2003-030659"},{"key":"2026070905553442500_CLAYTON-AND-CATT-1981","doi-asserted-by":"crossref","unstructured":"Clayton\n            RN\n           & Catt KJ 1981 Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocrine Reviews2186\u2013209.","DOI":"10.1210\/edrv-2-2-186"},{"key":"2026070905553442500_COLLIER-AND-KAPLAN-1984","unstructured":"Collier\n            RJ\n           & Kaplan DA 1984 Immunotoxins. Scientific American25156\u201364."},{"key":"2026070905553442500_CRAWFORD-2003","doi-asserted-by":"crossref","unstructured":"Crawford\n            ED\n          \n          2003 Early versus late hormonal therapy: debating the issues. Urology618\u201313.","DOI":"10.1016\/S0090-4295(02)02394-4"},{"key":"2026070905553442500_CRUMP-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Crump\n            M\n          , Sawka CA, DeBoer G, Buchanan RB, Ingle JN, Forbes J, Meakin JW, Shelley W & Pritchard KI 1997 An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Research and Treatment44201\u2013210.","DOI":"10.1023\/A:1005833811584"},{"key":"2026070905553442500_DAVIDSON-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Davidson\n            L\n          , Pawson AJ, Millar RP & Maudsley S 2004 Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. Journal of Biological Chemistry2791980\u20131993.","DOI":"10.1074\/jbc.M309827200"},{"key":"2026070905553442500_DENSMORE-AND-URBANSKI-2003","doi-asserted-by":"crossref","unstructured":"Densmore\n            VS\n           & Urbanski HF 2003 Relative effect of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on gonadotropin release. Journal of Clinical Endocrinology and Metabolism882126\u20132134.","DOI":"10.1210\/jc.2002-021359"},{"key":"2026070905553442500_DUFAU-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Dufau\n            ML\n          , Warren DW, Knox GF, Loumaye E, Castellon ML, Luna S & Catt KJ 1984 Receptors and inhibitory actions of gonadotropin-releasing hormone in the fetal Leydig cell. Journal of Biological Chemistry2592896\u20132899.","DOI":"10.1016\/S0021-9258(17)43232-7"},{"key":"2026070905553442500_ELLSWORTH-ETAL-2003A","doi-asserted-by":"crossref","unstructured":"Ellsworth\n            BS\n          , White BR, Burns AT, Cherrington BD, Otis AM & Clay CM 2003a c-Jun N-terminal kinase activation of activator protein-1 underlies homologous regulation of the gonadotropin-releasing hormone receptor gene in alpha T3-1 cells. Endocrinology144839\u2013849.","DOI":"10.1210\/en.2002-220784"},{"key":"2026070905553442500_ELLSWORTH-ETAL-2003B","doi-asserted-by":"crossref","unstructured":"Ellsworth\n            BS\n          , Burns AT, Escudero KW, Duval DL, Nelson SE & Clay CM 2003b The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Molecular and Cellular Endocrinology20693\u2013111.","DOI":"10.1016\/S0303-7207(03)00235-1"},{"key":"2026070905553442500_EMONS-AND-SCHALLY-1994","doi-asserted-by":"crossref","unstructured":"Emons\n            G\n           & Schally AV 1994 The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Human Reproduction91364\u20131379.","DOI":"10.1093\/oxfordjournals.humrep.a138714"},{"key":"2026070905553442500_EMONS-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Emons\n            G\n          , Schroder B, Ortmann O, Westphalen S, Schulz KD & Schally AV 1993 High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. Journal of Clinical Endocrinology and Metabolism771458\u20131464.","DOI":"10.1210\/jcem.77.6.8263128"},{"key":"2026070905553442500_EMONS-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Emons\n            G\n          , Ortmann O, Teichert HM, Fassl H, Lohrs U, Kullander S, Kauppila A, Ayalon D, Schally A & Oberheuser F 1996 Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group. Cancer781452\u20131460.","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1452::AID-CNCR12>3.0.CO;2-Z"},{"key":"2026070905553442500_EMONS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Emons\n            G\n          , Weiss S, Ortmann O, Grundker C & Schulz KD 2000 LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. European Journal of Endocrinology142665\u2013670.","DOI":"10.1530\/eje.0.1420665"},{"key":"2026070905553442500_EMONS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Emons\n            G\n          , Grundker C, Gunthert AR, Westphalen S, Kavanagh J & Verschraegen C 2003 GnRH antagonists in the treatment of gynecological and breast cancers. Endocrine-Related Cancer10291\u2013299.","DOI":"10.1677\/erc.0.0100291"},{"key":"2026070905553442500_FAURE-ETAL-1982","doi-asserted-by":"crossref","unstructured":"Faure\n            N\n          , Labrie F, Lemay A, Belanger A, Gourdeau Y, Laroche B & Robert G 1982 Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertility and Sterility37416\u2013424.","DOI":"10.1016\/S0015-0282(16)46107-8"},{"key":"2026070905553442500_FORTUNE-ETAL-1991","unstructured":"Fortune\n            JE\n          , Sirois J, Turzillo AM & Lavoir M 1991 Follicle selection in domestic ruminants. Journal of Reproduction and Fertility43 (Suppl) 187\u2013198."},{"key":"2026070905553442500_FRANKEL-ETAL-2000","unstructured":"Frankel\n            AE\n          , Kreitman RJ & Sausville EA 2000 Targeted toxins. Clinical Cancer Research6326\u2013334."},{"key":"2026070905553442500_FRIESS-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Friess\n            H\n          , Buchler M, Kiesel L, Kruger M & Beger HG 1991 LH-RH receptors in the human pancreas. Basis for antihormonal treatment in ductal carcinoma of the pancreas. International Journal of Pancreatology10151\u2013159.","DOI":"10.1007\/BF02924118"},{"key":"2026070905553442500_GAULT-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Gault\n            PM\n          , Maudsley S & Lincoln GA 2003 Evidence that gonadotropin-releasing hormone II is not a physiological regulator of gonadotropin secretion in mammals. Journal of Neuroendocrinology15831\u2013839.","DOI":"10.1046\/j.1365-2826.2003.01065.x"},{"key":"2026070905553442500_GOLDENBERG-ETAL-1999","unstructured":"Goldenberg\n            SL\n          , Gleave ME, Taylor D & Bruchovsky N 1999 Clinical experience with intermittent androgen suppression in prostate cancer: minimum of 3 years\u2019 follow-up. Molecular Urology3287\u2013292."},{"key":"2026070905553442500_GRANGER-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Granger\n            A\n          , Ngo-Muller V, Bleux C, Guigon C, Pincas H, Magre S, Daegelen D, Tixier-Vidal A, Counis R & Laverriere JN 2004 The promoter of the rat gonadotropin-releasing hormone receptor gene directs the expression of the human placental alkaline phosphatase reporter gene in gonadotrope cells in the anterior pituitary gland as well as in multiple extrapituitary tissues. Endocrinology145983\u2013993.","DOI":"10.1210\/en.2003-0881"},{"key":"2026070905553442500_VAN-GROENINGHEN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"van Groeninghen JC, Kiesel L, Winkler D & Zwirner M 1998 Effects of luteinising-hormone-releasing hormone on nervous-system tumours. Lancet352372\u2013373.","DOI":"10.1016\/S0140-6736(05)60472-2"},{"key":"2026070905553442500_GRUNDKER-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Grundker\n            C\n          , Volker P, Schulz KD & Emons G 2000a Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gynecologic Oncology78194\u2013202.","DOI":"10.1006\/gyno.2000.5863"},{"key":"2026070905553442500_GRUNDKER-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Grundker\n            C\n          , Schulz K, Gunthert AR & Emons G 2000b Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells. Journal of Clinical Endocrinology and Metabolism853815\u20133820.","DOI":"10.1210\/jc.85.10.3815"},{"key":"2026070905553442500_GRUNDKER-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Grundker\n            C\n          , Volker P & Emons G 2001 Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase. Endocrinology1422369\u20132380.","DOI":"10.1210\/endo.142.6.8190"},{"key":"2026070905553442500_GRUNDKER-ETAL-2002A","doi-asserted-by":"crossref","unstructured":"Grundker\n            C\n          , Gunthert AR, Millar RP & Emons G 2002a Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. Journal of Clinical Endocrinology and Metabolism871427\u20131430.","DOI":"10.1210\/jc.87.3.1427"},{"key":"2026070905553442500_GRUNDKER-ETAL-2002B","doi-asserted-by":"crossref","unstructured":"Grundker\n            C\n          , Gunthert AR, Westphalen S & Emons G 2002b Biology of the gonadotropin-releasing hormone system in gynecological cancers. European Journal of Endocrinology1461\u201314.","DOI":"10.1530\/eje.0.1460001"},{"key":"2026070905553442500_GUILLEMIN-1967","unstructured":"Guillemin\n            R\n          \n          1967 The adenohypophysis and its hypothalamic control. Annual Review of Physiology29313\u2013348."},{"key":"2026070905553442500_GUNTHER-ETAL-1993","unstructured":"Gunther\n            R\n          , Chelstrom LM, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers DE & Uckun FM 1993In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia\/lymphoma in mice with severe combined immunodeficiency. Leukemia7298\u2013309."},{"key":"2026070905553442500_DE-HAES-ETAL-2003","doi-asserted-by":"crossref","unstructured":"de Haes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W & Sauerbrei W 2003 Quality of life in goserelin-treated versus cyclophosphamide+methotrexate+fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group. Journal of Clinical Oncology214510\u20134516.","DOI":"10.1200\/JCO.2003.11.064"},{"key":"2026070905553442500_HALMOS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Halmos\n            G\n          , Arencibia JM, Schally AV, Davis R & Bostwick DG 2000 High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. Journal of Urology163623\u2013629.","DOI":"10.1097\/00005392-200002000-00062"},{"key":"2026070905553442500_HIGANO-2003","doi-asserted-by":"crossref","unstructured":"Higano\n            CS\n          \n          2003 Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology6132\u201338.","DOI":"10.1016\/S0090-4295(02)02397-X"},{"key":"2026070905553442500_HOFFKEN-1992","doi-asserted-by":"crossref","unstructured":"Hoffken\n            K\n          \n          1992 LH-RH agonists in the treatment of premenopausal patients with advanced breast cancer. Recent Results in Cancer Research12491\u2013104.","DOI":"10.1007\/978-88-470-2186-0_9"},{"key":"2026070905553442500_HUIRNE-AND-LAMBALK-2001","doi-asserted-by":"crossref","unstructured":"Huirne\n            JA\n           & Lambalk CB 2001 Gonadotropin-releasing-hormone-receptor antagonists. Lancet3581793\u20131803.","DOI":"10.1016\/S0140-6736(01)06797-6"},{"key":"2026070905553442500_IMAI-AND-TAMAYA-2000","doi-asserted-by":"crossref","unstructured":"Imai\n            A\n           & Tamaya T 2000 GnRH receptor and apoptotic signaling. Vitamins and Hormones591\u201333.","DOI":"10.1016\/S0083-6729(00)59002-5"},{"key":"2026070905553442500_IMAI-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Imai\n            A\n          , Ohno T, Iida K, Fuseya T, Furui T & Tamaya T 1994 Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types. Cancer742555\u20132561.","DOI":"10.1002\/1097-0142(19941101)74:9<2555::AID-CNCR2820740925>3.0.CO;2-X"},{"key":"2026070905553442500_JACOBS-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Jacobs\n            E\n          , Watson SA, Michaeli D, Ellis IO & Robertson JF 1999 Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts. British Journal of Cancer80352\u2013359.","DOI":"10.1038\/sj.bjc.6690362"},{"key":"2026070905553442500_JOHNSON-AND-THOMPSON-JR-1983","doi-asserted-by":"crossref","unstructured":"Johnson\n            L\n           & Thompson DL Jr 1983 Age-related and seasonal variation in the Sertoli cell population, daily sperm production and serum concentrations of follicle-stimulating hormone, luteinizing hormone and testosterone in stallions. Biology of Reproduction29777\u2013789.","DOI":"10.1095\/biolreprod29.3.777"},{"key":"2026070905553442500_JONAT-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Jonat\n            W\n          , Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A et al.2002 Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. Journal of Clinical Oncology204628\u20134635.","DOI":"10.1200\/JCO.2002.05.042"},{"key":"2026070905553442500_KAKAR-AND-JENNES-1995","doi-asserted-by":"crossref","unstructured":"Kakar\n            SS\n           & Jennes L 1995 Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Letters9857\u201362.","DOI":"10.1016\/S0304-3835(06)80010-8"},{"key":"2026070905553442500_KAKAR-ETAL-1994","unstructured":"Kakar\n            SS\n          , Grizzle WE & Neill JD 1994 The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Molecular and Cellular Endocrinology106145\u2013149."},{"key":"2026070905553442500_KANG-ETAL-2000","unstructured":"Kang\n            SK\n          , Cheng KW, Ngan ES, Chow BK, Choi KC & Leung PC 2000 Differential expression of human gonadotropin-releasing hormone receptor gene in pituitary and ovarian cells. Molecular and Cellular Endocrinology162157\u2013166."},{"key":"2026070905553442500_KANG-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Kang\n            SK\n          , Choi KC, Yang HS & Leung PC 2003 Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer. Endocrine - Related Cancer10169\u2013177.","DOI":"10.1677\/erc.0.0100169"},{"key":"2026070905553442500_KARTEN-AND-RIVIER-1986","doi-asserted-by":"crossref","unstructured":"Karten\n            MJ\n           & Rivier JE 1986 Gonadotropin-releasing hormone analog design. Structure\u2013function studies toward the development of agonists and antagonists: rationale and perspective. Endocrine Reviews744\u201366.","DOI":"10.1210\/edrv-7-1-44"},{"key":"2026070905553442500_KEENEY-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Keeney\n            DS\n          , Sprando RL, Robaire B, Zirkin BR & Ewing LL 1990 Reversal of long-term LH deprivation on testosterone secretion and Leydig cell volume, number and proliferation in adult rats. Journal of Endocrinology12747\u201358.","DOI":"10.1677\/joe.0.1270047"},{"key":"2026070905553442500_KOTTLER-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Kottler\n            ML\n          , Starzec A, Carre MC, Lagarde JP, Martin A & Counis R 1997 The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. International Journal of Cancer71595\u2013599.","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<595::AID-IJC14>3.3.CO;2-L"},{"key":"2026070905553442500_KOVACS-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Kovacs\n            M\n          , Schally AV, Nagy A, Koppan M & Groot K 1997 Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. PNAS941420\u20131425.","DOI":"10.1073\/pnas.94.4.1420"},{"key":"2026070905553442500_KRAUS-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Kraus\n            S\n          , Naor Z & Seger R 2001 Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Archives of Medical Research32499\u2013509.","DOI":"10.1016\/S0188-4409(01)00331-9"},{"key":"2026070905553442500_KRSMANOVIC-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Krsmanovic\n            LZ\n          , Mores N, Navarro CE, Arora KK & Catt KJ 2003 An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion. PNAS1002969\u20132974.","DOI":"10.1073\/pnas.0535708100"},{"key":"2026070905553442500_KUHN-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Kuhn\n            JM\n          , Billebaud T, Navratil H, Moulonguet A, Fiet J, Grise P, Louis JF, Costa P, Husson JM, Dahan R et al.1989 Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). New England Journal of Medicine321413\u2013418.","DOI":"10.1056\/NEJM198908173210701"},{"key":"2026070905553442500_LABRIE-1991","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          \n          1991 Endocrine therapy for prostate cancer. Endocrinology and Metabolism Clinics of North America20845\u2013872.","DOI":"10.1016\/S0889-8529(18)30247-0"},{"key":"2026070905553442500_LABRIE-2004","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          \n          2004 Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. Journal of Andrology25305\u2013313.","DOI":"10.1002\/j.1939-4640.2004.tb02791.x"},{"key":"2026070905553442500_LABRIE-ETAL-1980","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          , Belanger A, Cusan L, Seguin C, Pelletier G, Kelly PA, Reeves JJ, Lefebure FA, Lemay A & Ranaud JP 1980 Antifertility effects of LHRH agonists in the male. Journal of Andrology1209\u2013228.","DOI":"10.1002\/j.1939-4640.1980.tb00034.x"},{"key":"2026070905553442500_LABRIE-ETAL-1981","unstructured":"Labrie\n            F\n          , Belanger A, Kelly PA, Seguin C, Cusan L, Lefebvre FA, Reeves JJ, Lemay A, Faure N, Gourdeau Y et al.1981 Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists. Progress in Clinical and Biological Research74273\u2013291."},{"key":"2026070905553442500_LABRIE-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          , Dupont A, Belanger A, Emond J & Monfette G 1984 Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. PNAS813861\u20133863.","DOI":"10.1073\/pnas.81.12.3861"},{"key":"2026070905553442500_LABRIE-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          , Dupont A, Belanger A & Lachance R 1987 Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist. Journal of Urology138804\u2013806.","DOI":"10.1016\/S0022-5347(17)43380-5"},{"key":"2026070905553442500_LABRIE-ETAL-1993","unstructured":"Labrie\n            F\n          , Belanger A, Dupont A, Luu-The V, Simard J & Labrie C 1993 Science behind total androgen blockade: from gene to combination therapy. Clinical and Investigative Medicine16475\u2013492."},{"key":"2026070905553442500_LABRIE-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          , Belanger A, Cusan L, Simard J, Luu-The V, Labrie C, Gomez JL, Diamond P & Candas B 1996 History of LHRH agonist and combination therapy in prostate cancer. Endocrine-Related Cancer3243\u2013278.","DOI":"10.1677\/erc.0.0030243"},{"key":"2026070905553442500_LABRIE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Labrie\n            F\n          , Candas B, Gomez JL & Cusan L 2002 Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology60115\u2013119.","DOI":"10.1016\/S0090-4295(02)01639-4"},{"key":"2026070905553442500_LEE-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Lee\n            CY\n          , Ho J, Chow SN, Yasojima K, Schwab C & McGeer PL 2000 Immunoidentification of gonadotropin releasing hormone receptor in human sperm, pituitary and cancer cells. American Journal of Reproductive Immunology44170\u2013177.","DOI":"10.1111\/j.8755-8920.2000.440307.x"},{"key":"2026070905553442500_LETSCH-ETAL-2003","unstructured":"Letsch\n            M\n          , Schally AV, Szepeshazi K, Halmos G & Nagy A 2003 Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers. Clinical Cancer Research94505\u20134513."},{"key":"2026070905553442500_LIMONTA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Limonta\n            P\n          , Moretti RM, Marelli MM & Motta M 2003 The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Frontiers in Neuroendocrinology24279\u2013295.","DOI":"10.1016\/j.yfrne.2003.10.003"},{"key":"2026070905553442500_LIU-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Liu\n            F\n          , Usui I, Evans LG, Austin DA, Mellon PL, Olefsky JM & Webster NJ 2002 Involvement of both G(q\/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells. Journal of Biological Chemistry27732099\u201332108.","DOI":"10.1074\/jbc.M203639200"},{"key":"2026070905553442500_LIU-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Liu\n            F\n          , Austin DA & Webster NJ 2003 Gonadotropin-releasing hormone-desensitized LbetaT2 gonadotrope cells are refractory to acute protein kinase C, cyclic AMP, and calcium-dependent signaling. Endocrinology1444354\u20134365.","DOI":"10.1210\/en.2003-0204"},{"key":"2026070905553442500_LOBLAW-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Loblaw\n            DA\n          , Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ et al.2004 American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. Journal of Clinical Oncology222927\u20132941.","DOI":"10.1200\/JCO.2004.04.579"},{"key":"2026070905553442500_VAN-LOENEN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"van Loenen AC, Huirne JA, Schats R, Hompes PG & Lambalk CB 2002 GnRH agonists, antagonists, and assisted conception. Seminars in Reproductive Medicine20349\u2013364.","DOI":"10.1055\/s-2002-36713"},{"key":"2026070905553442500_LOVE-AND-PHILIPS-2002","unstructured":"Love\n            RR\n           & Philips J 2002 Oophorectomy for breast cancer: history revisited. Journal of the National Cancer Institute941433\u20131434."},{"key":"2026070905553442500_MCARDLE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"McArdle\n            CA\n          , Franklin J, Green L & Hislop JN 2002 Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. Journal of Endocrinology1731\u201311.","DOI":"10.1677\/joe.0.1730001"},{"key":"2026070905553442500_MACCOLL-ETAL-2002","doi-asserted-by":"crossref","unstructured":"MacColl\n            G\n          , Quinton R & Bouloux PM 2002 GnRH neuronal development: insights into hypogonadotrophic hypogonadism. Trends in Endocrinology and Metabolism13112\u2013118.","DOI":"10.1016\/S1043-2760(01)00545-8"},{"key":"2026070905553442500_MCCUE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"McCue\n            JM\n          , Quirk CC, Nelson SE, Bowen RA & Clay CM 1997 Expression of a murine gonadotropin-releasing hormone receptor\u2013luciferase fusion gene in transgenic mice is diminished by immunoneutralization of gonadotropin-releasing hormone. Endocrinology1383154\u20133160.","DOI":"10.1210\/endo.138.8.5306"},{"key":"2026070905553442500_MARCIL-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Marcil\n            J\n          , Ravindranath N & Sairam MR 1993 Cytotoxic activity of lutropin\u2013gelonin conjugate in mouse Leydig tumor cells: potentiation of the hormonotoxin activity by different drugs. Molecular and Cellular Endocrinology9283\u201390.","DOI":"10.1016\/0303-7207(93)90078-X"},{"key":"2026070905553442500_MESSING-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Messing\n            EM\n          , Manola J, Sarosdy M, Wilding G, Crawford ED & Trump D 1999 Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. New England Journal of Medicine3411781\u20131788.","DOI":"10.1056\/NEJM199912093412401"},{"key":"2026070905553442500_MILES-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Miles\n            LE\n          , Hanyaloglu AC, Dromey JR, Pfleger KD & Eidne KA 2004 Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized LbetaT2 gonadotrope and stable HEK293 cell lines. Endocrinology145194\u2013204.","DOI":"10.1210\/en.2003-0551"},{"key":"2026070905553442500_MILLER-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Miller\n            WR\n          , Scott WN, Morris R, Fraser HM & Sharpe RM 1985 Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature313231\u2013233.","DOI":"10.1038\/313231a0"},{"key":"2026070905553442500_MILLIKAN-AND-LOGOTHETICS-1997","unstructured":"Millikan\n            R\n           & Logothetics C 1997 National Comprehensive Cancer Network (NCC) Practice Guidelines version 1.97. Oncology11180\u2013201."},{"key":"2026070905553442500_MYERS-AND-VILLEMEZ-1989","doi-asserted-by":"crossref","unstructured":"Myers\n            DA\n           & Villemez CL 1989 A superactive hormonotoxin prepared with truncated diphtheria toxin. Biochemical and Biophysical Research Communications163161\u2013164.","DOI":"10.1016\/0006-291X(89)92114-1"},{"key":"2026070905553442500_NECHUSHTAN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Nechushtan\n            A\n          , Yarkoni S, Marianovsky I & Lorberboum-Galski H 1997 Adenocarcinoma cells are targeted by the new GnRH- PE66 chimeric toxin through specific gonadotropin-releasing hormone binding sites. Journal of Biological Chemistry27211597\u201311603.","DOI":"10.1074\/jbc.272.17.11597"},{"key":"2026070905553442500_NEILL-2002","doi-asserted-by":"crossref","unstructured":"Neill\n            JD\n          \n          2002 GnRH and GnRH receptor genes in the human genome. Endocrinology143737\u2013743.","DOI":"10.1210\/endo.143.3.8705"},{"key":"2026070905553442500_NICHOLS-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Nichols\n            J\n          , Foss F, Kuzel TM, LeMaistre CF, Platanias L, Ratain MJ, Rook A, Saleh M & Schwartz G 1997 Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies. European Journal of Cancer33 (Suppl 1) S34\u2013S36.","DOI":"10.1016\/S0959-8049(96)00327-9"},{"key":"2026070905553442500_NICHOLSON-AND-WALKER-1989","doi-asserted-by":"crossref","unstructured":"Nicholson\n            RI\n           & Walker KJ 1989 Gn-RH agonists in breast and gynaecologic cancer treatment. Journal of Steroid Biochemistry33801\u2013804.","DOI":"10.1016\/0022-4731(89)90496-2"},{"key":"2026070905553442500_NOCI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Noci\n            I\n          , Coronnello M, Borri P, Borrani E, Giachi M, Chieffi O, Marchionni M, Paglierani M, Buccoliero AM, Cherubini A et al.2000 Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. Cancer Letters15071\u201378.","DOI":"10.1016\/S0304-3835(99)00374-2"},{"key":"2026070905553442500_NORWITZ-ETAL-2002A","doi-asserted-by":"crossref","unstructured":"Norwitz\n            ER\n          , Xu S, Jeong KH, Bedecarrats GY, Winebrenner LD, Chin WW & Kaiser UB 2002a Activin A augments GnRH-mediated transcriptional activation of the mouse GnRH receptor gene. Endocrinology143985\u2013997.","DOI":"10.1210\/endo.143.3.8663"},{"key":"2026070905553442500_NORWITZ-ETAL-2002B","doi-asserted-by":"crossref","unstructured":"Norwitz\n            ER\n          , Xu S, Xu J, Spiryda LB, Park JS, Jeong KH, McGee EA & Kaiser UB 2002b Direct binding of AP-1 (Fos\/Jun) proteins to a SMAD binding element facilitates both gonadotropin-releasing hormone (GnRH)- and activin-mediated transcriptional activation of the mouse GnRH receptor gene. Journal of Biological Chemistry27737469\u201337478.","DOI":"10.1074\/jbc.M206571200"},{"key":"2026070905553442500_OEFELEIN-AND-RESNICK-2003","doi-asserted-by":"crossref","unstructured":"Oefelein\n            MG\n           & Resnick MI 2003 Effective testosterone suppression for patients with prostate cancer: is there a best castration? Urology62207\u2013213.","DOI":"10.1016\/S0090-4295(03)00331-5"},{"key":"2026070905553442500_OEFELEIN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Oefelein\n            MG\n          , Ricchiuti VS, Conrad PW, Goldman H, Bodner D, Resnick MI & Seftel A 2002 Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era. Urology60120\u2013124.","DOI":"10.1016\/S0090-4295(02)01633-3"},{"key":"2026070905553442500_OLSEN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Olsen\n            E\n          , Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P et al.2001 Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. Journal of Clinical Oncology19376\u2013388.","DOI":"10.1200\/JCO.2001.19.2.376"},{"key":"2026070905553442500_ORTMANN-AND-DIEDRICH-1999","doi-asserted-by":"crossref","unstructured":"Ortmann\n            O\n           & Diedrich K 1999 Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues. Human Reproduction14 (Suppl 1) 194\u2013206.","DOI":"10.1093\/humrep\/14.suppl_1.194"},{"key":"2026070905553442500_PAI-ETAL-1992","unstructured":"Pai\n            LH\n          , Batra JK, FitzGerald DJ, Willingham MC & Pastan I 1992 Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys. Cancer Research523189\u20133193."},{"key":"2026070905553442500_PATER-AND-PARULEKAR-2003","doi-asserted-by":"crossref","unstructured":"Pater\n            JL\n           & Parulekar WR 2003 Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer \u2014another step forward. Journal of the National Cancer Institute951811\u20131812.","DOI":"10.1093\/jnci\/djg133"},{"key":"2026070905553442500_PAWSON-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Pawson\n            AJ\n          , Morgan K, Maudsley SR & Millar RP 2003 Type II gonadotrophin-releasing hormone (GnRH-II) in reproductive biology. Reproduction126271\u2013278.","DOI":"10.1530\/rep.0.1260271"},{"key":"2026070905553442500_PETHER-ETAL-2003","unstructured":"Pether\n            M\n          , Goldenberg SL, Bhagirath K & Gleave M 2003 Intermittent androgen suppression in prostate cancer: an update of the Vancouver experience. Canadian Journal of Urology101809\u20131814."},{"key":"2026070905553442500_PILEPICH-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Pilepich\n            MV\n          , Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P et al.1995 Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology45616\u2013623.","DOI":"10.1016\/S0090-4295(99)80053-3"},{"key":"2026070905553442500_PITTELOUD-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Pitteloud\n            N\n          , Hayes FJ, Dwyer A, Boepple PA, Lee H & Crowley WF Jr 2002 Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism874128\u20134136.","DOI":"10.1210\/jc.2002-020518"},{"key":"2026070905553442500_POUND-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Pound\n            CR\n          , Partin AW, Eisenberger MA, Chan DW, Pearson JD & Walsh PC 1999 Natural history of progression after PSA elevation following radical prostatectomy. Journal of the American Medical Association2811591\u20131597.","DOI":"10.1097\/00005392-199910000-00103"},{"key":"2026070905553442500_PRITCHARD-2000","unstructured":"Pritchard\n            KI\n          \n          2000 Current and future directions in medical therapy for breast carcinoma: endocrine treatment. Cancer883065\u20133072."},{"key":"2026070905553442500_PRITCHARD-2002","doi-asserted-by":"crossref","unstructured":"Pritchard\n            KI\n          \n          2002 Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift? Journal of Clinical Oncology204611\u20134614.","DOI":"10.1200\/JCO.2002.20.24.4611"},{"key":"2026070905553442500_QI-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Qi\n            L\n          , Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA & Glode LM 2003 GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines. Urology Research31374\u2013377.","DOI":"10.1007\/s00240-003-0352-z"},{"key":"2026070905553442500_QI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Qi\n            L\n          , Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Crawford ED & Glode LM 2004 Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor. Cancer Research642090\u20132095.","DOI":"10.1158\/0008-5472.CAN-3192-2"},{"key":"2026070905553442500_QUELLA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Quella\n            SK\n          , Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, Antolak SJ Jr & Pisansky TM 1999 Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. Journal of Urology16298\u2013102.","DOI":"10.1097\/00005392-199907000-00024"},{"key":"2026070905553442500_ROELLE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Roelle\n            S\n          , Grosse R, Aigner A, Krell HW, Czubayko F & Gudermann T 2003 Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. Journal of Biological Chemistry27847307\u201347318.","DOI":"10.1074\/jbc.M304377200"},{"key":"2026070905553442500_RUF-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Ruf\n            F\n          , Fink MY & Sealfon SC 2003 Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Frontiers in Neuroendocrinology24181\u2013199.","DOI":"10.1016\/S0091-3022(03)00027-X"},{"key":"2026070905553442500_SABBATINI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Sabbatini\n            P\n          , Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C et al.1999 Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. Journal of Clinical Oncology17948\u2013957.","DOI":"10.1200\/JCO.1999.17.3.948"},{"key":"2026070905553442500_SABEUR-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Sabeur\n            K\n          , Ball BA, Nett TM, Ball HH & Liu IK 2003 Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs. Reproduction125801\u2013806.","DOI":"10.1530\/rep.0.1250801"},{"key":"2026070905553442500_SADIE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Sadie\n            H\n          , Styger G & Hapgood J 2003 Expression of the mouse gonadotropin-releasing hormone receptor gene in alpha T3-1 gonadotrope cells is stimulated by cyclic 3\u2032,5\u2032-adenosine monophosphate and protein kinase A, and is modulated by Steroidogenic factor-1 and Nur77. Endocrinology1441958\u20131971.","DOI":"10.1210\/en.2002-220874"},{"key":"2026070905553442500_SAMDAL-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Samdal\n            F\n          , Vada K, Lundmo PI & Mjolnerod OK 1991 Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate? Scandinavian Journal of Urology and Nephrology25197\u2013199.","DOI":"10.3109\/00365599109107946"},{"key":"2026070905553442500_SATO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Sato\n            N\n          , Gleave ME, Bruchovsky N, Rennie PS, Goldenberg SL, Lange PH & Sullivan LD 1996 Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. Journal of Steroid Biochemistry and Molecular Biology58139\u2013146.","DOI":"10.1016\/0960-0760(96)00018-0"},{"key":"2026070905553442500_SCHLICK-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Schlick\n            J\n          , Dulieu P, Desvoyes B, Adami P, Radom J & Jouvenot M 2000 Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines. FEBS Letters472241\u2013246.","DOI":"10.1016\/S0014-5793(00)01469-1"},{"key":"2026070905553442500_SCHWARTZ-AND-VALE-1988","doi-asserted-by":"crossref","unstructured":"Schwartz\n            J\n           & Vale W 1988 Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of CRF. Endocrinology1221695\u20131700.","DOI":"10.1210\/endo-122-4-1695"},{"key":"2026070905553442500_SCHWARTZ-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Schwartz\n            J\n          , Penke B, Rivier J & Vale W 1987 A new cytotoxin specific for the target cells of corticotropin-releasing factor. Endocrinology1211454\u20131460.","DOI":"10.1210\/endo-121-4-1454"},{"key":"2026070905553442500_SHAH-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Shah\n            BH\n          , Farshori MP, Jambusaria A & Catt KJ 2003 Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1\/2 responses to gonadotropin-releasing hormone receptor activation. Journal of Biological Chemistry27819118\u201319126.","DOI":"10.1074\/jbc.M212932200"},{"key":"2026070905553442500_SIMMS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Simms\n            MS\n          , Scholfield DP, Jacobs E, Michaeli D, Broome P, Humphreys JE & Bishop MC 2000 Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer. British Journal of Cancer83443\u2013446.","DOI":"10.1054\/bjoc.2000.1315"},{"key":"2026070905553442500_SINGH-AND-CURTISS-1991","unstructured":"Singh\n            V\n           & Curtiss R 3rd 1991 Hormonotoxins: abrogation of ribosome inactivating property of gelonin in the disulfide linked ovine luteinizing hormone-gelonin conjugates. Biochemistry International25531\u2013536."},{"key":"2026070905553442500_SINGH-AND-CURTISS-1994","doi-asserted-by":"crossref","unstructured":"Singh\n            V\n           & Curtiss R 3rd 1994 Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugates. Molecular and Cellular Biochemistry13091\u2013101.","DOI":"10.1007\/BF01084272"},{"key":"2026070905553442500_SMITH-2003","unstructured":"Smith\n            MR\n          \n          2003 Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer97789\u2013795."},{"key":"2026070905553442500_STRAUB-ETAL-2001","unstructured":"Straub\n            B\n          , Muller M, Krause H, Schrader M, Goessl C, Heicappell R & Miller K 2001 Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers. Clinical Cancer Research72340\u20132343."},{"key":"2026070905553442500_SUNDERLAND-AND-OSBORNE-1991","unstructured":"Sunderland\n            MC\n           & Osborne CK 1991 Tamoxifen in premenopausal patients with metastatic breast cancer: a review. Journal of Clinical Oncology91283\u20131297."},{"key":"2026070905553442500_SZOKE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Szoke\n            B\n          , Horvath J, Halmos G, Rekasi Z, Groot K, Nagy A & Schally AV 1994 LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro. Peptides15359\u2013366.","DOI":"10.1016\/0196-9781(94)90024-8"},{"key":"2026070905553442500_TAYLOR-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Taylor\n            CW\n          , Green S, Dalton WS, Martino S, Rector D, Ingle JN, Robert NJ, Budd GT, Paradelo JC, Natale RB et al.1998 Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. Journal of Clinical Oncology16994\u2013999.","DOI":"10.1200\/JCO.1998.16.3.994"},{"key":"2026070905553442500_TERASAWA-2003","doi-asserted-by":"crossref","unstructured":"Terasawa\n            E\n          \n          2003 Gonadotropin-releasing hormone II: is this neuropeptide important for mammalian reproduction? Endocrinology1443\u20134.","DOI":"10.1210\/en.2002-0010"},{"key":"2026070905553442500_TERASAWA-AND-FERNANDEZ-2001","doi-asserted-by":"crossref","unstructured":"Terasawa\n            E\n           & Fernandez DL 2001 Neurobiological mechanisms of the onset of puberty in primates. Endocrine Reviews22111\u2013151.","DOI":"10.1210\/edrv.22.1.0418"},{"key":"2026070905553442500_THRUSH-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Thrush\n            GR\n          , Lark LR, Clinchy BC & Vitetta ES 1996 Immunotoxins: an update. Annual Review of Immunology1449\u201371.","DOI":"10.1146\/annurev.immunol.14.1.49"},{"key":"2026070905553442500_TOBET-ETAL-2001","unstructured":"Tobet\n            SA\n          , Bless EP & Schwarting GA 2001 Developmental aspect of the gonadotropin-releasing hormone system. Molecular and Cellular Endocrinology185173\u2013184."},{"key":"2026070905553442500_TRACHTENBERG-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Trachtenberg\n            J\n          , Gittleman M, Steidle C, Barzell W, Friedel W, Pessis D, Fotheringham N, Campion M & Garnick MB 2002 A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer. Journal of Urology1671670\u20131674.","DOI":"10.1097\/00005392-200204000-00021"},{"key":"2026070905553442500_UCKUN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Uckun\n            FM\n          , Bellomy K, O\u2019Neill K, Messinger Y, Johnson T & Chen CL 1999 Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus. Journal of Pharmacology and Experimental Therapeutics2911301\u20131307.","DOI":"10.1016\/S0022-3565(24)35240-1"},{"key":"2026070905553442500_VASILYEV-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Vasilyev\n            VV\n          , Lawson MA, Dipaolo D, Webster NJ & Mellon PL 2002 Different signaling pathways control acute induction versus long-term repression of LHbeta transcription by GnRH. Endocrinology1433414\u20133426.","DOI":"10.1210\/en.2001-211215"},{"key":"2026070905553442500_VICKERY-1986","doi-asserted-by":"crossref","unstructured":"Vickery\n            BH\n          \n          1986 Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists. Endocrine Reviews7115\u2013124.","DOI":"10.1210\/edrv-7-1-115"},{"key":"2026070905553442500_VIRGOLINI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Virgolini\n            I\n          , Traub T, Novotny C, Leimer M, Fuger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M et al.2002 Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Current Pharmaceutical Design81781\u20131807.","DOI":"10.2174\/1381612023393756"},{"key":"2026070905553442500_DE-VOOGT-ETAL-1989","doi-asserted-by":"crossref","unstructured":"de Voogt HJ, Suciu S, Sylvester R, Pavone-Macaluso M, Smith PH & de Pauw M 1989 Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials. Journal of Urology141883\u2013888.","DOI":"10.1016\/S0022-5347(17)41039-1"},{"key":"2026070905553442500_WANG-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Wang\n            Y\n          , Matsuo H, Kurachi O & Maruo T 2002 Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells. European Journal of Endocrinology146447\u2013456.","DOI":"10.1530\/eje.0.1460447"},{"key":"2026070905553442500_WARNER-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Warner\n            B\n          , Worgul TJ, Drago J, Demers L, Dufau M, Max D & Santen RJ 1983 Effect of very high dose d-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic\u2013pituitary testicular axis in patients with prostatic cancer. Journal of Clinical Investigation711842\u20131853.","DOI":"10.1172\/JCI110940"},{"key":"2026070905553442500_WEINBAUER-AND-NIESCHLAG-1992","doi-asserted-by":"crossref","unstructured":"Weinbauer\n            GF\n           & Nieschlag E 1992 LH-RH antagonists: state of the art and future perspectives. Recent Results in Cancer Research124113\u2013136.","DOI":"10.1007\/978-88-470-2186-0_11"},{"key":"2026070905553442500_WIERMAN-1996","unstructured":"Wierman ME 1996 Gonadotropin-releasing hormone. In Reproductive Endocrinology, Surgery, and Technology, pp 666\u2013681. Eds EY Adashi, JA Rock & Z Rosewaks. Philadelphia: Lippincott-Raven Publishers."},{"key":"2026070905553442500_WIERMAN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Wierman\n            ME\n          , Pawlowski JE, Allen MP, Xu M, Linseman DA & Nielsen-Preiss S 2004 Molecular mechanisms of gonadotropin-releasing hormone neuronal migration. Trends in Endocrinology and Metabolism1596\u2013102.","DOI":"10.1016\/j.tem.2004.02.003"},{"key":"2026070905553442500_XU-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Xu\n            C\n          , Xu XZ, Nunemaker CS & Moenter SM 2004 Dose-dependent switch in response of gonadotropin-releasing hormone (GnRH) neurons to GnRH mediated through the type I GnRH receptor. Endocrinology145728\u2013735.","DOI":"10.1210\/en.2003-0562"},{"key":"2026070905553442500_YANG-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Yang\n            WH\n          , Wieczorck M, Allen MC & Nett TM 2003 Cytotoxic activity of gonadotropin-releasing hormone (GnRH)-pokeweed antiviral protein conjugates in cell lines expressing GnRH receptors. Endocrinology1441456\u20131463.","DOI":"10.1210\/en.2002-220917"},{"key":"2026070905553442500_YIN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Yin\n            H\n          , Cheng KW, Hwa HL, Peng C, Auersperg N & Leung PC 1998 Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines. Life Sciences622015\u20132023.","DOI":"10.1016\/S0024-3205(98)00173-8"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/11\/4\/0110725.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/11\/4\/725\/149683\/0110725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/11\/4\/725\/149683\/0110725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:55:54Z","timestamp":1783590954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/11\/4\/725\/26651\/Gonadotropin-releasing-hormone-and-its-receptor-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":166,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.00777","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}